Pressure may grow on companies to repatriate production, raising production costs and potentially medicine prices too.
The WHO’s 2025 report highlights global disparities in the detection of substandard and falsified medical products, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback